In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression
Clopidogrel, a P2Y12 receptor antagonist, is widely used to prevent cardiovascular events, but significant variability in its efficacy persists among patients. AKR1D1, involved in bile acid synthesis and regulation of CYP enzymes, may contribute to this variability. This study aims to investigate wh...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-03-01
|
| Series: | Balkan Journal of Medical Genetics |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/bjmg-2024-0012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850073652259717120 |
|---|---|
| author | Shutevska K Kadifkova Panovska T Zhivikj Z Kapedanovska Nestorovska A |
| author_facet | Shutevska K Kadifkova Panovska T Zhivikj Z Kapedanovska Nestorovska A |
| author_sort | Shutevska K |
| collection | DOAJ |
| description | Clopidogrel, a P2Y12 receptor antagonist, is widely used to prevent cardiovascular events, but significant variability in its efficacy persists among patients. AKR1D1, involved in bile acid synthesis and regulation of CYP enzymes, may contribute to this variability. This study aims to investigate whether clopidogrel and its inactive metabolite, 2-oxoclopidogrel, interact with AKR1D1 at the enzymatic or transcriptional level. Enzymatic activity assays demonstrated that neither clopidogrel nor 2-oxoclopidogrel acts as a substrate or inhibitor of AKR1D1. Expression studies in HepG2 cells further revealed no significant changes in AKR1D1 mRNA levels following treatment with these compounds. These findings indicate that clopidogrel does not directly influence AKR1D1’s metabolic functions, including bile acid synthesis, steroid hormone clearance, or the production of 5β-reduced steroids, which regulate CYP enzyme expression. From a physiological perspective, the absence of interaction minimizes the risk of adverse effects on CYP-mediated drug metabolism, nutrient absorption, lipid digestion, and the absorption of lipophilic drugs. Future research should explore AKR1D1’s broader substrate specificity, particularly focusing on non-steroidal compounds, and investigate the clinical implications of AKR1D1 polymorphisms in clopidogrel-treated patients to enhance personalized therapeutic strategies. |
| format | Article |
| id | doaj-art-ea36fb1443e54021b384b671575d4545 |
| institution | DOAJ |
| issn | 2199-5761 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Balkan Journal of Medical Genetics |
| spelling | doaj-art-ea36fb1443e54021b384b671575d45452025-08-20T02:46:46ZengSciendoBalkan Journal of Medical Genetics2199-57612025-03-01272697510.2478/bjmg-2024-0012In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene ExpressionShutevska K0Kadifkova Panovska T1Zhivikj Z2Kapedanovska Nestorovska A3University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy, Institute of applied biochemistry, Majka Tereza 47, 1000Skopje, Republic of North Macedonia.University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy, Institute of applied biochemistry, Majka Tereza 47, 1000Skopje, Republic of North Macedonia.University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy, Institute of applied biochemistry, Majka Tereza 47, 1000Skopje, Republic of North Macedonia.University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy, Institute of pharmaceutical chemistry, Majka Tereza 47, 1000Skopje, Republic of North Macedonia.Clopidogrel, a P2Y12 receptor antagonist, is widely used to prevent cardiovascular events, but significant variability in its efficacy persists among patients. AKR1D1, involved in bile acid synthesis and regulation of CYP enzymes, may contribute to this variability. This study aims to investigate whether clopidogrel and its inactive metabolite, 2-oxoclopidogrel, interact with AKR1D1 at the enzymatic or transcriptional level. Enzymatic activity assays demonstrated that neither clopidogrel nor 2-oxoclopidogrel acts as a substrate or inhibitor of AKR1D1. Expression studies in HepG2 cells further revealed no significant changes in AKR1D1 mRNA levels following treatment with these compounds. These findings indicate that clopidogrel does not directly influence AKR1D1’s metabolic functions, including bile acid synthesis, steroid hormone clearance, or the production of 5β-reduced steroids, which regulate CYP enzyme expression. From a physiological perspective, the absence of interaction minimizes the risk of adverse effects on CYP-mediated drug metabolism, nutrient absorption, lipid digestion, and the absorption of lipophilic drugs. Future research should explore AKR1D1’s broader substrate specificity, particularly focusing on non-steroidal compounds, and investigate the clinical implications of AKR1D1 polymorphisms in clopidogrel-treated patients to enhance personalized therapeutic strategies.https://doi.org/10.2478/bjmg-2024-0012akr1d1clopidogreldrug metabolismenzyme interactionpharmacogenomicsgene expression |
| spellingShingle | Shutevska K Kadifkova Panovska T Zhivikj Z Kapedanovska Nestorovska A In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression Balkan Journal of Medical Genetics akr1d1 clopidogrel drug metabolism enzyme interaction pharmacogenomics gene expression |
| title | In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression |
| title_full | In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression |
| title_fullStr | In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression |
| title_full_unstemmed | In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression |
| title_short | In Vitro Analysis of AKR1D1 Interactions with Clopidogrel: Effects on Enzyme Activity and Gene Expression |
| title_sort | in vitro analysis of akr1d1 interactions with clopidogrel effects on enzyme activity and gene expression |
| topic | akr1d1 clopidogrel drug metabolism enzyme interaction pharmacogenomics gene expression |
| url | https://doi.org/10.2478/bjmg-2024-0012 |
| work_keys_str_mv | AT shutevskak invitroanalysisofakr1d1interactionswithclopidogreleffectsonenzymeactivityandgeneexpression AT kadifkovapanovskat invitroanalysisofakr1d1interactionswithclopidogreleffectsonenzymeactivityandgeneexpression AT zhivikjz invitroanalysisofakr1d1interactionswithclopidogreleffectsonenzymeactivityandgeneexpression AT kapedanovskanestorovskaa invitroanalysisofakr1d1interactionswithclopidogreleffectsonenzymeactivityandgeneexpression |